DE69308146D1 - Überwachungsverfahren - Google Patents

Überwachungsverfahren

Info

Publication number
DE69308146D1
DE69308146D1 DE69308146T DE69308146T DE69308146D1 DE 69308146 D1 DE69308146 D1 DE 69308146D1 DE 69308146 T DE69308146 T DE 69308146T DE 69308146 T DE69308146 T DE 69308146T DE 69308146 D1 DE69308146 D1 DE 69308146D1
Authority
DE
Germany
Prior art keywords
ovulation
current
cycle
status
ovulation cycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69308146T
Other languages
English (en)
Other versions
DE69308146T2 (de
Inventor
Michael Brampton Close Catt
John The Avenue Coley
Paul Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere Switzerland GmbH
Original Assignee
Unipath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unipath Ltd filed Critical Unipath Ltd
Publication of DE69308146D1 publication Critical patent/DE69308146D1/de
Application granted granted Critical
Publication of DE69308146T2 publication Critical patent/DE69308146T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0012—Ovulation-period determination
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Holo Graphy (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Control Of Eletrric Generators (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DE69308146T 1992-08-21 1993-08-10 Überwachungsverfahren Expired - Fee Related DE69308146T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929217866A GB9217866D0 (en) 1992-08-21 1992-08-21 Monitoring method
PCT/EP1993/002146 WO1994004924A1 (en) 1992-08-21 1993-08-10 Monitoring method

Publications (2)

Publication Number Publication Date
DE69308146D1 true DE69308146D1 (de) 1997-03-27
DE69308146T2 DE69308146T2 (de) 1997-07-10

Family

ID=10720775

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69308146T Expired - Fee Related DE69308146T2 (de) 1992-08-21 1993-08-10 Überwachungsverfahren
DE69331113T Expired - Fee Related DE69331113T2 (de) 1992-08-21 1993-08-10 Überwachungsverfahren

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69331113T Expired - Fee Related DE69331113T2 (de) 1992-08-21 1993-08-10 Überwachungsverfahren

Country Status (20)

Country Link
EP (2) EP0745853B1 (de)
JP (3) JP3149111B2 (de)
KR (1) KR950703147A (de)
AT (2) ATE148945T1 (de)
AU (2) AU4709293A (de)
BG (1) BG62061B1 (de)
BR (1) BR9306939A (de)
CA (1) CA2142263C (de)
DE (2) DE69308146T2 (de)
DK (2) DK0656118T3 (de)
ES (2) ES2100555T3 (de)
FI (1) FI950717A (de)
GB (1) GB9217866D0 (de)
GR (1) GR3023397T3 (de)
NO (1) NO950635L (de)
NZ (1) NZ254821A (de)
PL (1) PL307570A1 (de)
PT (1) PT745853E (de)
RU (1) RU2146059C1 (de)
WO (1) WO1994004924A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2335983A (en) * 1998-04-02 1999-10-06 Unilever Plc Estimating time of maximum fertility
CA2335793A1 (en) * 1998-06-22 1999-12-29 Medi-Cult A/S A method for in vitro maturation of human gametes
US6080118A (en) * 1999-02-25 2000-06-27 Blythe; Cleveland Vaginal probe and method of using same
US6764825B1 (en) 2000-10-13 2004-07-20 Tang J. Wang Methods and device for detecting prostate specific antigen (PSA)
US6592529B2 (en) * 2001-07-31 2003-07-15 Pheromone Sciences Corp. Method and device for predicting the fertile phase of women
US20040181172A1 (en) 2003-03-12 2004-09-16 Carney Fiona Patricia Devices for collecting analytes of interest in tears
US20040181167A1 (en) 2003-03-13 2004-09-16 Carney Fiona Patricia Method and kits for monitoring women's health
CN102183663A (zh) * 2011-03-24 2011-09-14 武汉璟泓万方堂医药科技有限公司 定性半定量两用检测女性排卵激素试纸及比色卡
GB201402668D0 (en) * 2014-02-14 2014-04-02 Concepta Diagnostics Ltd Fertility and pregnancy monitoring device and method
KR101963427B1 (ko) * 2016-11-23 2019-03-28 주시회사 바이탈스미스 여성호르몬(에스트로겐) 주기 측정을 위한 영상처리 및 분석 시스템, 이의 제어 방법
CN109890297A (zh) * 2016-10-28 2019-06-14 株式会社马尼金 用于确定排卵日的影像处理和分析系统及其控制方法
US20190261960A1 (en) * 2016-10-28 2019-08-29 Manigene Co., Ltd. Image processing and analyzing system for ovulation detection and method for controlling same
KR101855488B1 (ko) * 2016-11-23 2018-06-11 주식회사 바이탈스미스 여성호르몬(에스트로겐) 주기를 통한 배란일 예측 장치
US11029321B2 (en) 2017-02-17 2021-06-08 MFB Fertility, Inc. Method of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
WO2021034412A1 (en) * 2019-08-19 2021-02-25 MFB Fertility, Inc. Systems and methods for menstrual cycle testing
US11061026B2 (en) 2017-02-17 2021-07-13 MFB Fertility, Inc. System of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
US11131665B1 (en) 2018-08-22 2021-09-28 MFB Fertility, Inc. Method for evaluating urine of a subject to estimate the fertile window
EP3731751A4 (de) * 2017-12-28 2021-10-13 MFB Fertility, Inc. Systeme und verfahren zur verfolgung von progesteron

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE225509T1 (de) * 1987-04-27 2002-10-15 Inverness Medical Switzerland Testgerät zur durchführung von spezifischen bindungsprüfungen
US5118630A (en) * 1988-11-04 1992-06-02 Quidel Corporation Method for determining periodic infertility in females

Also Published As

Publication number Publication date
RU2146059C1 (ru) 2000-02-27
DK0656118T3 (da) 1997-08-18
AU4709293A (en) 1994-03-15
GR3023397T3 (en) 1997-08-29
NO950635L (no) 1995-04-20
BG62061B1 (bg) 1999-01-29
JPH08500669A (ja) 1996-01-23
ES2100555T3 (es) 1997-06-16
EP0745853A1 (de) 1996-12-04
EP0656118A1 (de) 1995-06-07
NO950635D0 (no) 1995-02-20
ATE148945T1 (de) 1997-02-15
EP0745853B1 (de) 2001-11-07
NZ254821A (en) 1997-04-24
AU5631898A (en) 1998-05-21
KR950703147A (ko) 1995-08-23
EP0656118B1 (de) 1997-02-12
DK0745853T3 (da) 2002-02-11
ATE208503T1 (de) 2001-11-15
DE69308146T2 (de) 1997-07-10
FI950717A0 (fi) 1995-02-17
JPH10185914A (ja) 1998-07-14
CA2142263A1 (en) 1994-03-03
GB9217866D0 (en) 1992-10-07
BG99435A (bg) 1995-12-29
JP2001178729A (ja) 2001-07-03
BR9306939A (pt) 1999-01-12
DE69331113D1 (de) 2001-12-13
CA2142263C (en) 2003-02-11
JP3149111B2 (ja) 2001-03-26
PT745853E (pt) 2002-04-29
WO1994004924A1 (en) 1994-03-03
DE69331113T2 (de) 2002-06-20
ES2167492T3 (es) 2002-05-16
FI950717A (fi) 1995-02-17
PL307570A1 (en) 1995-05-29

Similar Documents

Publication Publication Date Title
DE69308147D1 (de) Überwachungsverfahren und test kits
DE69308146D1 (de) Überwachungsverfahren
GB9217865D0 (en) Monitoring method
ATE213333T1 (de) Überwachungsverfahren
PL312299A1 (en) Method of as well as apparatus and test set for monitoring ovulation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INVERNESS MEDICAL SWITZERLAND GMBH, ZUG, CH

8328 Change in the person/name/address of the agent

Representative=s name: MEISSNER, BOLTE & PARTNER GBR, 80538 MUENCHEN

8339 Ceased/non-payment of the annual fee